Page last updated: 2024-09-05

lapatinib and nadp

lapatinib has been researched along with nadp in 3 studies

Compound Research Comparison

Studies (lapatinib)	Trials (lapatinib)	Recent Studies (post-2010) (lapatinib)	Studies (nadp)	Trials (nadp)	Recent Studies (post-2010) (nadp)
1,919	305	1,442	21,608	25	3,484

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Chan, EC; Chua, TB; Ho, HK; Nelson, SD; New, LS; Yap, CW	1
Alexander, PB; Chen, J; Chen, R; Ding, Y; Gong, C; Li, QJ; Liang, G; Lin, KH; Song, EW; Sui, P; Wang, QF; Wang, XF; Wood, KC; Xiang, H; Yin, T; Yuan, L	1
Cai, N; Cheng, K; Liang, H; Wen, J; Xiong, Y; Zhang, W; Zhang, Y; Zhu, J	1

Reviews

1 review(s) available for lapatinib and nadp

Article	Year
The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors. Oxidative medicine and cellular longevity, 2020, Volume: 2020 Topics: Acetaminophen; Antineoplastic Agents; Antioxidants; Apoptosis; Artemisinins; Auranofin; Cell Death; Cisplatin; Epigenesis, Genetic; Fatty Acids; Ferroptosis; Haloperidol; Humans; Indoles; Iron; Lapatinib; Mevalonic Acid; NADP; Neoplasms; Oxidation-Reduction; Oxidative Stress; Oxygen; Quinolines; Reactive Oxygen Species; Sorafenib; Spiro Compounds; Sulfasalazine; Trigonella	2020

Article

Year

The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors.

Oxidative medicine and cellular longevity, 2020, Volume: 2020

Topics: Acetaminophen; Antineoplastic Agents; Antioxidants; Apoptosis; Artemisinins; Auranofin; Cell Death; Cisplatin; Epigenesis, Genetic; Fatty Acids; Ferroptosis; Haloperidol; Humans; Indoles; Iron; Lapatinib; Mevalonic Acid; NADP; Neoplasms; Oxidation-Reduction; Oxidative Stress; Oxygen; Quinolines; Reactive Oxygen Species; Sorafenib; Spiro Compounds; Sulfasalazine; Trigonella

2020

Other Studies

2 other study(ies) available for lapatinib and nadp

Article	Year
Interaction of lapatinib with cytochrome P450 3A5. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:7 Topics: Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dealkylation; Humans; Hydroxylation; Lapatinib; Midazolam; NADP; Protein Kinase Inhibitors; Quinazolines; Testosterone	2012
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers. Nature communications, 2018, 10-15, Volume: 9, Issue:1 Topics: Breast Neoplasms; Cell Death; Cell Line, Tumor; CRISPR-Cas Systems; Drug Resistance, Neoplasm; Female; Genetic Testing; HEK293 Cells; Humans; Lapatinib; Metabolic Flux Analysis; NADP; Pentose Phosphate Pathway; Receptor, ErbB-2; Synthetic Lethal Mutations; Transaldolase	2018

Article

Year

Interaction of lapatinib with cytochrome P450 3A5.

Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:7

Topics: Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dealkylation; Humans; Hydroxylation; Lapatinib; Midazolam; NADP; Protein Kinase Inhibitors; Quinazolines; Testosterone

2012

Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers.

Nature communications, 2018, 10-15, Volume: 9, Issue:1

Topics: Breast Neoplasms; Cell Death; Cell Line, Tumor; CRISPR-Cas Systems; Drug Resistance, Neoplasm; Female; Genetic Testing; HEK293 Cells; Humans; Lapatinib; Metabolic Flux Analysis; NADP; Pentose Phosphate Pathway; Receptor, ErbB-2; Synthetic Lethal Mutations; Transaldolase

2018